Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows

v3.21.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Operating activities    
Net loss $ (17,551) $ (13,088)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 164 153
Stock-based compensation expense 2,505 1,998
Net accretion and amortization of investments in marketable securities 196 (205)
Changes in assets and liabilities:    
Interest receivable and other current assets 299 310
Prepaid research and development expenses and other prepaid assets (2,852) 1,951
Other assets (1,239) 0
Accounts payable 1,375 (1,290)
Accrued liabilities (3,458) (4,537)
Net cash used in operating activities (20,561) (14,708)
Investing activities    
Purchases of property and equipment (94) 0
Purchases of marketable securities (18,212) (65,503)
Proceeds from maturities of marketable securities 54,000 112,136
Net cash provided by investing activities 35,694 46,633
Financing activities    
Net cash provided by financing activities 0 0
Net increase in cash and cash equivalents 15,133 31,925
Cash and cash equivalents at beginning of period 28,193 24,869
Cash and cash equivalents at end of period 43,326 56,794
Supplemental disclosure    
Cash paid for amounts included in the measurement of lease liabilities $ 166 $ 161